Back to Search
JENNIFER KAPLAN, MD
MD
Pediatric Critical Care Medicine Physician
NPI: 1407899529IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatrics — Pediatric Critical Care Medicine
Code: 2080P0203X
OH35.080978(OH)
CMS Specialties
PrimaryCRITICAL CARE (INTENSIVISTS)
Education
UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE
Class of 1999
Research & Publications (20)
Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
PMID 17621259·Shock·2007
8-other
Inpatient verbal orders and the impact of computerized provider order entry.
PMID 17011314·J Pediatr·2006
8-other
Inhibitors of poly (ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration.
PMID 15718920·Shock·2005
7-preclinical
15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock.
PMID 15988322·Shock·2005
7-preclinical
Breast reduction: does the tumescent technique affect reimbursement?
PMID 18766030·Plast Reconstr Surg·2008
4-observational
Therapeutic benefit of treatment with anti-thymocyte globulin and latent TGF-beta1 in the MRL/lpr lupus mouse model.
PMID 18755864·Lupus·2008
7-preclinical
Lawsuits against plastic surgeons: Does locale affect incidence of claims?
PMID 19554148·Can J Plast Surg·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3333 BURNET AVE ML 2005
CINCINNATI, OH 45229 - Phone
- (513) 636-4259
Quick Facts
- NPI
- 1407899529
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile